MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Hippocampal-striatal interaction and cognitive decline in Parkinson’s disease with mild cognitive impairment

S. Tan, X. Zhang, J. Wen, X. Xu, Z. Zhang, J. Xu (Hangzhou, China)

Meeting: 2025 International Congress

Keywords: Cognitive dysfunction, Hippocampus, Presynaptic dopaminergic system

Category: Parkinson's disease: Neuroimaging

Objective: We aimed to investigate the interaction between hippocampus and dopaminergic pathways in PD with mild cognitive impairment (PD-MCI).

Background: Dysfunction of striatal dopaminergic neurotransmitter system and hippocampus are key contributors to cognitive disorders in Parkinson’s disease (PD). However, the interaction between dopaminergic deficits and hippocampal dysfunction in PD-related cognitive decline remains unclear.

Method: 33 PD-MCI and 20 PD with normal cognition (PD-NC) were included from the Parkinson’s Progression Markers Initiative (PPMI) (Table 1). All patients underwent motor and cognitive assessments, 18F-AV-133 vesicular monoamine transporter 2 PET imaging, and T1-weighted MRI. Asymmetry indices (AI) were calculated for striatal 18F-AV-133 standard uptake volume ratio (SUVR) and hippocampal subfield volumes. Partial correlation and multivariate regression models examined associations with cognition and potential interaction effects.

Results: PD-MCI showed higher AI in caudate and anterior putamen SUVR versus PD-NC (Table 2). Hippocampal CA2/3 AI negatively correlated with MoCA (p=0.045) and HVLT (p=0.022), and granule cell layer AI correlated with lower MoCA (p=0.047) . Striatal SUVR AI (caudate/anterior putamen) negatively linked to multiple cognitive domains (Table 3). Regression analysis revealed interactions between anterior putamen SUVR AI and CA2/3 AI on MoCA in PD group (p=0.039), and posterior putamen SUVR AI with CA2/3 AI in PD-MCI (p=0.002) (Table 4, Table 5).

Conclusion: Striatal dopaminergic denervation and hippocampal atrophy exhibit a cooperative interaction on cognitive decline in PD. Lateralized dopaminergic deficits in the anterior putamen and CA2/3 atrophy jointly contribute to cognitive impairment. These findings clarified the relationship between hippocampus and dopaminergic pathways in PD with cognitive decline, and deepen understanding of the pathophysiological mechanisms of cognitive impairment.

Table 1

Table 1

Table 2

Table 2

Table 3

Table 3

Table 4

Table 4

Table 5

Table 5

To cite this abstract in AMA style:

S. Tan, X. Zhang, J. Wen, X. Xu, Z. Zhang, J. Xu. Hippocampal-striatal interaction and cognitive decline in Parkinson’s disease with mild cognitive impairment [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/hippocampal-striatal-interaction-and-cognitive-decline-in-parkinsons-disease-with-mild-cognitive-impairment/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/hippocampal-striatal-interaction-and-cognitive-decline-in-parkinsons-disease-with-mild-cognitive-impairment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley